NEWS

• How to Join
• Renew Membership
• News
• Events
• Publications
• Presentations
• Corporate Sponsors
• Associate Members
• Links

SPONSORS

Strategic Case Studies

2:00 p.m. -3:00 p.m.

Joel Cheng

Executive Vice President, XPhase Pharmaceuticals

Joel is one of the co-founder of XPhase Pharmaceutical Inc. He was the Senior Director of PharmEng International and Managing Director of PharmEng Innovations from April 2006. He was from MDS SCIEX, where he has served as the Director of Sales for New Products. Joel was chiefly responsible for MDS SCIEX's $280 million in annual sales revenue. Joel's 26-year career began in 1980 with Hewlett Packard/Agilent Technologies, where he maintained leadership positions in strategic, operational and corporate management capacities across North America. Joel has since maintained positions of increasing responsibility including Major Account Representative, Western Canada Business Team Manager and Worldwide Channel Manager. A native of Hong Kong, China, Joel graduated from Waterloo University with a Bachelor's Co-op degree in Chemistry/Biochemistry.

Bin Huang

President and Chief Executive Officer, WEX Pharmaceuticals

Dr. Huang joined the company in November 2007. Her previous experience includes 2 years as CEO of GeneHarbour Technologies (Hong Kong) and 5 years as President and CEO of Cytovax Biotechnologies Inc. in Canada. Additionally, she served as Vice President of Business Development at Monsanto Canada, and was a top-ranked biotech analyst in Canada while she was a partner at GMP Securities. Dr. Huang received her PhD in cell biology from the University of East Anglia, UK, and her MBA from the University of Toronto.

Fulong Qiao

Dr. Fulong Qiao is the founder of Beijing Farmunity Inc. Before starting his business, Dr. Qiao has accumulated 20 years of experiences in the field of both Chinese dairy and international dairy since he started his Master?s degree on ruminant nutrition in 1988 in China Agricultural University. In 1996, Dr. Qiao enrolled in the research project on dairy nutrition and equipped with valuable experiences in cutting-edge dairy management methodologies. In 2002, Dr. Qiao completed his Ph.D. program from University of Guelph. Since February, 2004, Dr. Qiao has been dedicating to establish an integrated dairy corporation from forage producing, dairy producing and dairy processing and marketing to overcome all of the challenging issues of Chinese dairy facing. During these years in China, Dr. Qiao has developed an innovative integrated dairy producing technology system (IDPTS) with his technical team in Beijing, which was officially evaluated by Beijing Science and Technology Commission in June, 2006. The IDPTS has been widely implemented in existing dairy farms in Beijing, Hebei province and Inner Mongolia. As a result of applying this technology, the milk yield for each lactating cow increases 20 - 50%, and the quality of raw milk has improved significantly and met the international standard. The first dairy cooperative farm which was co-invested by a private company and local dairy farmers, ?Dairyunited Cooperative?, has been successfully established by Dr. Qiao and his colleagues in Huhhot, the capital of Inner Mongolia. Dr. Qiao gained excellent reputation for his dedicated contribution to Chinese dairy industry. At present, Dr. Qiao is focusing on establishing an integrated eco-dairy corporation model including developing forage producing cooperatives, revising and managing existing dairy farms, producing superior dairy products through OEM, and marketing by direct-sale membership system in Beijing. The optimal goal of Farmunity Inc. is to establish a highly integrated international eco-farming corporation to supply wide range of safe and high quality foods for the growing food market in China.

Sean Thompson

Vice President, Corporate Development, YM Biosciences

Mr. Thompson is responsible for all aspects of corporate development for YM, including licensing, identifying targets for M&A and development partnerships. He has a solid background in clinical development and big Pharma marketing experience, and was previously Director of Clinical Research for YM. Prior to YM he worked for Roche, sitting on the Global Business Team in virology, and was Clinical Research Manager. Prior to Roche, he was a Clinical Scientist for SmithKline Beecham developing products for oncology, respiratory and CNS disorders. He is currently Vice Chair of the BIOTECanada Health Policy Advisory Board, a member of the Ontario Institute for Cancer Research Industry Advisory Board and was previously a Board member for Variation Biotechnologies Inc. Mr. Thompson holds a Bachelor of Science degree from the University of Waterloo.




Back to Conference Program